Christer Bergquist

No ORCID on file · 11 papers in corpus · active 1984-2005

Study types

  • article 11

Condition tags

  • endometriosis 7
  • mesh:D004715 6
  • infertility 2
  • mesh:D004716 1
article 2005
·doi:10.1080/j.0001-6349.2005.00658.x

Background. Retrospective studies have indicated differences in sexuality and general psychological well-being between women who have undergone hysterectomy only and those undergoing hysterectomy and oophorectomy. These differences may be t…

article 2005
·doi:10.1016/j.fertnstert.2004.12.008
article 2004
·doi:10.1016/j.maturitas.2004.08.018
article 2000
Lakartidningen

The aim of pharmacological treatment of endometriosis is to reduce estrogen levels, which may be achieved using gestagens or GnRH-agonists. The effects of the different hormones are mainly the same, while side effects differ. If the GnRH-ag…

article 2000
Lakartidningen

Endometriosis is a common disease with serious consequences for the patient and for society. Until now there has been no reliable method for diagnosing endometriosis besides direct visualization, e.g. utilizing laparoscopy. IVF offers the m…

article 1997
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(97)70084-x
article 1992
·doi:10.1016/0020-7292(92)90702-k
article 1991
Lakartidningen
article 1990
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(90)90438-d
article 1989
The Journal of reproductive medicine

The preliminary results from an ongoing multicenter trial further support the efficacy and excellent tolerability of nafarelin in the management of endometriosis.

article 1984
Upsala journal of medical sciences ·doi:10.3109/03009738409178474

This paper presents the initial results from a study that used a new superagonist of gonadotrophin-releasing hormone (GnRH), naferelin acetate, for the inhibition of ovulation. The superagonist was administered by nasal spray daily for 12 w…